Healthcare Journal of Oregon: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 13, 2026

Apr. 13, 2026

Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement

GlobeNewswire

Apr. 13, 2026

Nanox Signs Distribution Agreement with Digital X-Ray Imaging to Expand Nanox.ARC Adoption in Arkansas

GlobeNewswire

Apr. 13, 2026

Veld Pharmaceuticals GmbH Announces Collaboration with Chiesi Farmaceutici S.p.A to Expand Access to Rare Disease Therapies Across Africa

GlobeNewswire

Apr. 13, 2026

ImPact Biotech Presents Preliminary Data from Phase 1 Study of Padeliporfin VTP in LA-PDAC at SIR 2026 and Provides Strategic Business Update

GlobeNewswire

Apr. 13, 2026

Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary

GlobeNewswire

Apr. 13, 2026

Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures

GlobeNewswire

Apr. 13, 2026

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

GlobeNewswire

Apr. 13, 2026

Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism

GlobeNewswire

Apr. 13, 2026

Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference

GlobeNewswire

Apr. 13, 2026

Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

GlobeNewswire

Apr. 13, 2026

Praxis to Showcase Essential3, the First Positive Phase 3 Program in Essential Tremor, at AAN 2026

GlobeNewswire

Apr. 13, 2026

CVRx Reports Preliminary First Quarter 2026 Financial Results

GlobeNewswire

Apr. 13, 2026

Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

GlobeNewswire

Apr. 13, 2026

Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire

Apr. 13, 2026

Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090

GlobeNewswire

Apr. 13, 2026

Catheter Precision Announces Accepted Publication in Leading European Medical Journal

GlobeNewswire

Apr. 13, 2026

NervGen Pharma to Participate in the H.C. Wainwright "HCW@Home" Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire

Apr. 13, 2026

With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository

GlobeNewswire

Apr. 13, 2026

Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL

GlobeNewswire

Apr. 13, 2026

Vireo Growth Announces California Retail Joint Venture with Glass House Brands

GlobeNewswire